Annual report pursuant to Section 13 and 15(d)

Accrued Expenses and Other Current Liabilities (Details)

v3.20.1
Accrued Expenses and Other Current Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Accrued Expenses and Other Current Liabilities      
Compensation and benefits $ 1,786 $ 1,524  
Restructuring (severance) 0 1,419 $ 1,077
Pharmaceutical development expenses 445 231  
Accrued interest 18 88  
Other accrued expenses and other current liabilities 154 33  
Total accrued expenses and other current liabilities $ 2,403 $ 3,295